Elite Pharmaceuticals, Inc.
Michael C. is a seasoned financial professional with extensive experience in accounting and financial analysis, currently serving as a Senior Accountant/Cost Analyst at Elite Pharmaceuticals, Inc. since September 2019. Previous roles include Senior Financial Analyst Consultant at Jansy and Cost Accounting Project Consultant at Chromalloy New York. Michael has also worked on SAP implementations and business integrations at companies such as BD and Maquet Getinge Group. A strong background in financial reporting, project accounting, and cost analysis is complemented by a Bachelor's degree in Accounting and Finance from William Paterson University of New Jersey.
This person is not in any teams
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite has four ANDA products partnered with TAGI Pharma; one ANDA has launched, two ANDAs are in the process of a manufacturing site transfer and an additional ANDA is currently under review by the FDA. Elite also manufactures Lodrane D® and receives royalties for Lodrane D®, an allergy product partnered with ECR Pharmaceuticals (“ECR”), a wholly owned subsidiary of Hi-Tech Pharmacal (“Hi-Tech”). Elite’s lead pipeline products, ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also has partnered with Mikah Pharma to develop a new product and with Hi-Tech Pharmacal to develop an intermediate for a generic product. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.